Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

$Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis$

Journal article

Peer reviewed

Robert R. Recker, J. A. Stakkestad, C. H. Chesnut, C. Christiansen, A. Skag, A. Hoiseth, M. Ettinger, P. Mahoney, R. C. Schimmer and D. P. Delmas

Bone, Vol.34(5), pp.890-899

05/2004

PMID: 15121021

Metrics

6 Record Views

Title: Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis
Creators: Robert R. Recker (Author) - Creighton University
J. A. Stakkestad (Author)
C. H. Chesnut (Author)
C. Christiansen (Author)
A. Skag (Author)
A. Hoiseth (Author)
M. Ettinger (Author)
P. Mahoney (Author)
R. C. Schimmer (Author)
D. P. Delmas (Author)
Additional links: http://dx.doi.org/10.1016/j.bone.2004.01.008
Publication Details: Bone, Vol.34(5), pp.890-899
Number of pages: 890-899
Identifiers: 991005932507402656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article